Kidney and Liver Transplantation in HIV-Infected Patients

Case Presentations and Review

Michelle E. Roland, Deborah Adey, Laurie L. Carlson, Norah A. Terrault

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Until recently, HIV-infected patients have been excluded from consideration for solid organ transplantation. The relatively high mortality rates among HIV-infected transplant recipients observed in the era prior to the use of highly active antiretroviral therapy (HAART), coupled with long waiting times for cadaveric organs, made it difficult to support organ transplantation in this patient group. However, in response to the marked reductions in morbidity and mortality associated with HIV infection, several transplant centers have developed pilot studies or revised their clinical criteria to allow transplantation in this group of patients. We describe two cases, one kidney and one liver transplant recipient, and review the major clinical and research issues related to this topic. Reports of transplantations in the pre-HAART era highlight two important findings. First, some HIV-infected transplant recipients did very well with long survival periods. However, overall progression to AIDS and death appeared accelerated. We recently reported on our preliminary experience with 45 selected transplant recipients in the HAART era. One-year patient survival rates were similar to unmatched survival data from the United Network for Organ Sharing (UNOS) database. Median CD4+ T-cell counts remained stable in the follow-up period compared to pretransplant. HIV-1 RNA nearly uniformly continued to be suppressed below the limits of detection. Preliminary data are promising and support the current efforts to evaluate patient and graft survival among HIV-infected transplant recipients and to explore the mechanisms underlying the many potential complications of transplantation in this population.

Original languageEnglish (US)
Pages (from-to)501-507
Number of pages7
JournalAIDS Patient Care and STDs
Volume17
Issue number10
DOIs
StatePublished - Oct 2003

Fingerprint

Liver Transplantation
Kidney Transplantation
HIV
Highly Active Antiretroviral Therapy
Transplantation
Organ Transplantation
Survival
Mortality
Graft Survival
CD4 Lymphocyte Count
HIV Infections
Limit of Detection
HIV-1
Acquired Immunodeficiency Syndrome
Survival Rate
Transplant Recipients
Databases
RNA
Morbidity
T-Lymphocytes

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Leadership and Management
  • Nursing(all)

Cite this

Kidney and Liver Transplantation in HIV-Infected Patients : Case Presentations and Review. / Roland, Michelle E.; Adey, Deborah; Carlson, Laurie L.; Terrault, Norah A.

In: AIDS Patient Care and STDs, Vol. 17, No. 10, 10.2003, p. 501-507.

Research output: Contribution to journalArticle

Roland, Michelle E. ; Adey, Deborah ; Carlson, Laurie L. ; Terrault, Norah A. / Kidney and Liver Transplantation in HIV-Infected Patients : Case Presentations and Review. In: AIDS Patient Care and STDs. 2003 ; Vol. 17, No. 10. pp. 501-507.
@article{6717669cbf1242af9236248dc9b78fc3,
title = "Kidney and Liver Transplantation in HIV-Infected Patients: Case Presentations and Review",
abstract = "Until recently, HIV-infected patients have been excluded from consideration for solid organ transplantation. The relatively high mortality rates among HIV-infected transplant recipients observed in the era prior to the use of highly active antiretroviral therapy (HAART), coupled with long waiting times for cadaveric organs, made it difficult to support organ transplantation in this patient group. However, in response to the marked reductions in morbidity and mortality associated with HIV infection, several transplant centers have developed pilot studies or revised their clinical criteria to allow transplantation in this group of patients. We describe two cases, one kidney and one liver transplant recipient, and review the major clinical and research issues related to this topic. Reports of transplantations in the pre-HAART era highlight two important findings. First, some HIV-infected transplant recipients did very well with long survival periods. However, overall progression to AIDS and death appeared accelerated. We recently reported on our preliminary experience with 45 selected transplant recipients in the HAART era. One-year patient survival rates were similar to unmatched survival data from the United Network for Organ Sharing (UNOS) database. Median CD4+ T-cell counts remained stable in the follow-up period compared to pretransplant. HIV-1 RNA nearly uniformly continued to be suppressed below the limits of detection. Preliminary data are promising and support the current efforts to evaluate patient and graft survival among HIV-infected transplant recipients and to explore the mechanisms underlying the many potential complications of transplantation in this population.",
author = "Roland, {Michelle E.} and Deborah Adey and Carlson, {Laurie L.} and Terrault, {Norah A.}",
year = "2003",
month = "10",
doi = "10.1089/108729103322494294",
language = "English (US)",
volume = "17",
pages = "501--507",
journal = "AIDS Patient Care and STDs",
issn = "1087-2914",
publisher = "Mary Ann Liebert Inc.",
number = "10",

}

TY - JOUR

T1 - Kidney and Liver Transplantation in HIV-Infected Patients

T2 - Case Presentations and Review

AU - Roland, Michelle E.

AU - Adey, Deborah

AU - Carlson, Laurie L.

AU - Terrault, Norah A.

PY - 2003/10

Y1 - 2003/10

N2 - Until recently, HIV-infected patients have been excluded from consideration for solid organ transplantation. The relatively high mortality rates among HIV-infected transplant recipients observed in the era prior to the use of highly active antiretroviral therapy (HAART), coupled with long waiting times for cadaveric organs, made it difficult to support organ transplantation in this patient group. However, in response to the marked reductions in morbidity and mortality associated with HIV infection, several transplant centers have developed pilot studies or revised their clinical criteria to allow transplantation in this group of patients. We describe two cases, one kidney and one liver transplant recipient, and review the major clinical and research issues related to this topic. Reports of transplantations in the pre-HAART era highlight two important findings. First, some HIV-infected transplant recipients did very well with long survival periods. However, overall progression to AIDS and death appeared accelerated. We recently reported on our preliminary experience with 45 selected transplant recipients in the HAART era. One-year patient survival rates were similar to unmatched survival data from the United Network for Organ Sharing (UNOS) database. Median CD4+ T-cell counts remained stable in the follow-up period compared to pretransplant. HIV-1 RNA nearly uniformly continued to be suppressed below the limits of detection. Preliminary data are promising and support the current efforts to evaluate patient and graft survival among HIV-infected transplant recipients and to explore the mechanisms underlying the many potential complications of transplantation in this population.

AB - Until recently, HIV-infected patients have been excluded from consideration for solid organ transplantation. The relatively high mortality rates among HIV-infected transplant recipients observed in the era prior to the use of highly active antiretroviral therapy (HAART), coupled with long waiting times for cadaveric organs, made it difficult to support organ transplantation in this patient group. However, in response to the marked reductions in morbidity and mortality associated with HIV infection, several transplant centers have developed pilot studies or revised their clinical criteria to allow transplantation in this group of patients. We describe two cases, one kidney and one liver transplant recipient, and review the major clinical and research issues related to this topic. Reports of transplantations in the pre-HAART era highlight two important findings. First, some HIV-infected transplant recipients did very well with long survival periods. However, overall progression to AIDS and death appeared accelerated. We recently reported on our preliminary experience with 45 selected transplant recipients in the HAART era. One-year patient survival rates were similar to unmatched survival data from the United Network for Organ Sharing (UNOS) database. Median CD4+ T-cell counts remained stable in the follow-up period compared to pretransplant. HIV-1 RNA nearly uniformly continued to be suppressed below the limits of detection. Preliminary data are promising and support the current efforts to evaluate patient and graft survival among HIV-infected transplant recipients and to explore the mechanisms underlying the many potential complications of transplantation in this population.

UR - http://www.scopus.com/inward/record.url?scp=0242318405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0242318405&partnerID=8YFLogxK

U2 - 10.1089/108729103322494294

DO - 10.1089/108729103322494294

M3 - Article

VL - 17

SP - 501

EP - 507

JO - AIDS Patient Care and STDs

JF - AIDS Patient Care and STDs

SN - 1087-2914

IS - 10

ER -